Altimmune, Inc. (ALT) Tops Q4 EPS by 7c

Altimmune, Inc. (NASDAQ: ALT) reported Q4 EPS of ($0.43), $0.07 better than the analyst estimate of ($0.50).

For earnings history and earnings-related data on Altimmune, Inc. (ALT) click here.

You May Also Be Interested In

• 'Ocean of opportunity': Wolfe initiates SpaceX at Buy ahead of historic IPO
• MIND Technology (MIND) Misses Q1 EPS by 5c
• BIG3 Basketball to go public via Graf Global merger at $290 million